LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
Clinical trial NCT05313529 · COMPLETED
Trial details
- NCT number
- NCT05313529
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-08
- Primary completion
- 2025-12-31
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.